Skip to main content
Elie Traer, MD, Oncology, Portland, OR

ElieTraerMD

Oncology • Portland, OR

OHSU

Join to view full profile

Dr. Traer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Traer's full profile

Already have an account?

  • Office

    3181 SW Sam Jackson Park Road, 2nd Floor, Portland, OR
    Portland, OR 97239
    Phone+1 503-494-5058

Education & Training

  • Oregon Health & Science University (OHSU Health)
    Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2006 - 2009
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolClass of 2006
  • Oregon Health & Science University (OHSU Health)
    Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2009 - 2025
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Phase Ib Study of the Anti-TIM-3 Antibody MBG453 in Combination with Decitabine in Patients with High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
    Elie Traer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Maturing Clinical Profile of IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate, in Patients with Relapsed or Refractory Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Dr. Elie Traer, Dr. Elie Traer, MD, Dr. E Traer